-
1دورية أكاديمية
المؤلفون: Katja Seipel, Mariesol Abbühl, Ulrike Bacher, Henning Nilius, Michael Daskalakis, Thomas Pabst
المصدر: Cancers, Vol 15, Iss 11, p 3058 (2023)
مصطلحات موضوعية: B-lymphocyte antigen CD19, single nucleotide polymorphism (SNP), minor allele frequency (MAF), CAR-T cell therapy, FMC63-chimeric antigen receptor (FMC63-CAR), Tisagenlecleucel (Kymriah©), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Cédric Gillich, Dilara Akhoundova, Michael Hayoz, Yolanda Aebi, Carlo R. Largiadèr, Katja Seipel, Michael Daskalakis, Ulrike Bacher, Thomas Pabst
المصدر: Cancers, Vol 15, Iss 10, p 2699 (2023)
مصطلحات موضوعية: multiple myeloma (MM), treosulfan, pharmacokinetics, efficacy, response rate, overall survival (OS), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Selina Bühler, Dilara Akhoundova, Barbara Jeker, Myriam Legros, Katja Seipel, Michael Daskalakis, Ulrike Bacher, Thomas Pabst
المصدر: Cancers, Vol 15, Iss 2, p 430 (2023)
مصطلحات موضوعية: multiple myeloma, stem cell mobilization, autologous stem cell transplantation (ASCT), ixazomib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Vera Rentsch, Katja Seipel, Yara Banz, Gertrud Wiedemann, Naomi Porret, Ulrike Bacher, Thomas Pabst
المصدر: Cancers, Vol 14, Iss 10, p 2516 (2022)
مصطلحات موضوعية: CAR T-cell therapy, glofitamab, diffuse large B-cell lymphoma (DLBCL), relapse, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
5دورية أكاديمية
المؤلفون: Katja Seipel, Basil Kopp, Ulrike Bacher, Thomas Pabst
المصدر: Cancers, Vol 13, Iss 3, p 581 (2021)
مصطلحات موضوعية: acute myeloid leukemia (AML), B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1), hematopoietic progenitor cell antigen cluster of differentiation 34 (CD34), meningioma 1 (MN1), myelodysplastic syndrome (MDS), myeloid cell leukemia 1 (MCL1), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
6دورية أكاديمية
المؤلفون: Jeffrey R. Idle, Katja Seipel, Ulrike Bacher, Thomas Pabst, Diren Beyoğlu
المصدر: Cancers, Vol 12, Iss 10, p 2842 (2020)
مصطلحات موضوعية: acute myeloid leukemia, isocitrate dehydrogenase 1, isocitrate dehydrogenase 2, metabolomics, biomarker, (2R)-hydroxyglutaric acid, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
7دورية أكاديميةRationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia
المؤلفون: Katja Seipel, Karin Schmitter, Ulrike Bacher, Thomas Pabst
المصدر: Cancers, Vol 11, Iss 11, p 1779 (2019)
مصطلحات موضوعية: acute myeloid leukemia (aml), fms like tyrosine kinase 3 (flt3), hematological malignancies, mitogen-activated protein kinase kinase (mek, map2k, mapkk), myeloid leukemia cell differentiation protein (mcl1), ribosomal protein s6 (rps6), tumor suppressor p53 (tp53), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
8دورية أكاديمية
المؤلفون: Beatrice U. Mueller, Katja Seipel, Ulrike Bacher, Thomas Pabst
المصدر: Cancers, Vol 10, Iss 9, p 340 (2018)
مصطلحات موضوعية: AML, autologous, transplantation, older, elderly, outcome, survival, review, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
9دورية أكاديمية
المصدر: Cancers, Vol 10, Iss 6, p 170 (2018)
مصطلحات موضوعية: acute myeloid leukemia (AML), FMS like tyrosine kinase 3 (FLT3), tumor suppressor p53 (TP53), mouse double minute 2 homolog (MDM2), mitogen-activated protein kinase kinase (MEK, MAP2K, MAPKK), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
10
المؤلفون: Ulrike Bacher, Basil Kopp, Thomas Pabst, Katja Seipel
المصدر: Cancers, Vol 13, Iss 581, p 581 (2021)
Cancers
Volume 13
Issue 3
Seipel, Katja; Kopp, Basil; Bacher, Ulrike; Pabst, Thomas (2021). BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia. Cancers, 13(3) MDPI AG 10.3390/cancers13030581 <http://dx.doi.org/10.3390/cancers13030581Test>مصطلحات موضوعية: 0301 basic medicine, Cancer Research, NPM1, CD34, 610 Medicine & health, BMI1 Inhibitor PTC596, myeloid cell leukemia 1 (MCL1), lcsh:RC254-282, Article, 03 medical and health sciences, meningioma 1 (MN1), 0302 clinical medicine, acute myeloid leukemia (AML), hemic and lymphatic diseases, Medicine, MCL1, neoplasms, Trametinib, Acute leukemia, business.industry, MEK inhibitor, Myeloid leukemia, myelodysplastic syndrome (MDS), lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 3. Good health, B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1), 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, tumor suppressor protein 53 (TP53), Cancer research, business, hematopoietic progenitor cell antigen cluster of differentiation 34 (CD34)
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ba1f36042ffd3cdb925c7e8e62782eTest
https://www.mdpi.com/2072-6694/13/3/581Test